27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
During economic downturns, private technology companies often seek emergency funding from existing V...
Read More >
On September 15, 2020, the US Department of the Treasury issued a Final Rule comprising the latest r...
Read More >
In Germany, employees enjoy rather strong protection against termination of employment. Additionally...
Read More >
Nevada has undergone a significant transformation regarding the legal landscape affecting Nevada’s ...
Read More >
On January 31, 2020, the World Health Organization has announced the outbreak of novel coronavirus (...
Read More >
USCIS has published the latest version of Form I-9. Employers should begin using the new version sta...
Read More >